WHO MAKES THE DIABETES DRUG COPYRIGHT NO FURTHER A MYSTERY

In March 2025, the company announced new strategies for a immediate-to-customer offering of its Wegovy weight loss drug. The company recognized a completely new pharmacy, called NovoCare, which would charge prospects $499 monthly for access to the drug, a lot less than half the cost of the drug through other pharmaceutical distribution networks.[fi